Oncothermia

It was discovered in Germany and is used worldwide. It has been scientifically proven to kill cancer cells and can be used in addition to both conservative and alternative therapies.

Hyperthermia is one of the primary therapeutic methods for the treatment of cancer. It is a primary method because it is cancerkilling. But it has other, auxiliary modes of action: It aids chemotherapy and radiation therapy. This is why it is usually applied in combination with these methods, but also with other treatments, which are called complementary.

Oncothermia is the most up-to-date evolution of hyperthermia (scientific name: modulated electro-hyperthermia, modulated electro hyperthermia, mEHT). Oncothermia differs from other primary therapies in that it stimulates the immune system against cancer, while all other therapies suppress it.

It is a recognized medical practice in all European Union countries, the United States and all medically advanced countries. It has been booming in recent years in Japan, China and Korea. oncotherapy session.

Oncothermia is completely painless, with no complications or side effects, and is also completely safe because it does not use ionizing radiation. It uses a dense alternating electric field, properly configured to induce nanoparticle stimulation of the cells membrane (lipid rafts). These stimulated nanoparticles, through complex biochemical pathways, eventually cause the death of the cancer cell, in a natural way, called apoptosis.

Hyperthermia - Oncothermia

Clinical Effectiveness and Usefulness

The picture shows at a glance the clinical effectiveness of hyperthermia, based on the 2004 Kadota clinical consesus, which first demonstrated the usefulness of the method for the cancer patient. For details and bibliography of Kadota click here. The conclusion of the Kadota Consensus is that hyperthermia is a cancerkilling, immunostimulatory treatment without side effects, which also aids conventional therapies, that is, it has additional usefulness. In particular oncothermia creates the conditions for the production of specific immune cells (dendritic cells) directed against the malignant tumor. Therefore, in newer studies, it is also classified in immunomodulatory therapies.

Hyperthermia is also a officially recognized medical practice in Greece, based on decision article number 3, of the 232nd plenary session of KESY (6/9/2011). In Europe it is scientifically supervised by the European Society of Hyperthermic Oncology (ESHO), while in various countries it is supervised by local hyperthermia medical companies. In Greece the supervisory scientific authority is the Hellenic Society of Hyperthermical Oncology (HeSHO).